Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and α-cyclodextrin sulfate

被引:1
|
作者
Sugiuchi, H
Irie, T
Uji, Y
Ueno, T
Chaen, T
Uekama, K
Okabe, H
机构
[1] Kumamoto Univ Hosp, Dept Cent Lab, Kumamoto 860, Japan
[2] Kumamoto Univ, Fac Pharmaceut Sci, Kumamoto 862, Japan
[3] Kumamoto Univ, Sch Med, Dept Lab Med, Kumamoto 862, Japan
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We have developed a fully automated method for measuring LDL-cholesterol (LDL-C) in human serum without the need for prior separation, using a nonionic surfactant, polyoxyethylene-polyoxypropylene block copolyether (POE-POP), and a sodium salt of sulfated cyclic maltohexaose, alpha-cyclodextrin sulfate. Of the surfactants tested, POE-POP with a higher molecular mass of the POP block and a greater hydrophobicity reduced the reactivity of cholesterol in lipoprotein fractions; the reactivity in descending order was LDL much greater than VLDL > chylomicron approximate to HDL. Gel filtration chromatographic studies revealed that POE-POP removed lipids selectively from the LDL fraction and allowed them to participate in the cholesterol esterase-cholesterol oxidase coupling reaction system. By contrast, alpha-cyclodextrin sulfate reduced the reactivity of cholesterol, especially in chylomicrons and VLDL. A combination of POE-POP with alpha-cyclodextrin sulfate provided the required selectivity for the determination of LDL-C in serum in the presence of magnesium ions and a small amount of dextran sulfate without precipitating lipoprotein aggregates. There was a good correlation between the results of LDL-C assayed by the proposed method and the beta-quantification reference method involving 161 sera with triglyceride concentrations ranging from 0.3 to 22.6 mmol/L.
引用
收藏
页码:522 / 531
页数:10
相关论文
共 50 条
  • [31] Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol
    deGoma, Emil M.
    Leeper, Nicholas J.
    Heidenreich, Paul A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) : 49 - 55
  • [32] Low low-density lipoprotein cholesterol and cancer risk
    Strandberg, Timo E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (01) : 91 - 92
  • [33] Reliability of Calculated Low-Density Lipoprotein Cholesterol
    Meeusen, Jeffrey W.
    Snozek, Christine L.
    Baumann, Nikola A.
    Jaffe, Allan S.
    Saenger, Amy K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (04): : 538 - 540
  • [34] Alirocumab for low-density lipoprotein cholesterol lowering
    Roth, Eli M.
    FUTURE CARDIOLOGY, 2019, 15 (01) : 17 - 29
  • [35] STEPWISE DEGRADATION OF SERUM LOW-DENSITY LIPOPROTEIN BY SODIUM DODECYL-SULFATE
    IKAI, A
    JOURNAL OF BIOCHEMISTRY, 1976, 79 (03): : 679 - 688
  • [36] Low-density lipoprotein cholesterol in subclinical hypothyroidism
    Vierhapper, H
    Nardi, A
    Grösser, P
    Raber, W
    Gessl, A
    THYROID, 2000, 10 (11) : 981 - 984
  • [37] LOW-DENSITY LIPOPROTEIN, LIVER AND CHOLESTEROL TRANSPORT
    SNIDERMAN, A
    TENG, B
    MARPOLE, D
    TANSER, P
    JERRY, M
    CLINICAL RESEARCH, 1975, 23 (03): : A333 - A333
  • [38] Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)-Free Low-Density Lipoprotein Cholesterol
    Zheng, Weili
    Chilazi, Michael
    Park, Jihwan
    Sathiyakumar, Vasanth
    Donato, Leslie J.
    Meeusen, Jeffrey W.
    Lazo, Mariana
    Guallar, Eliseo
    Kulkarni, Krishnaji R.
    Jaffe, Allan S.
    Santos, Raul D.
    Toth, Peter P.
    Jones, Steven R.
    Martin, Seth S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (02):
  • [39] Statins and low-density lipoprotein cholesterol levels
    Cohen, JS
    AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01): : 74 - 75
  • [40] Low-density lipoprotein cholesterol targets in 2003
    Faergeman, O
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2003, 5 (0D) : D3 - D7